The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial.
Annals of Internal Medicine（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined